Direktorat Registrasi ObatValid

XENIFAR

BPOM Number: DKL9609206004B1
Approved: 21 November 2024
Expiry: 7 March 2028
Form: KAPLET; 550 MG

About This Registration

XENIFAR is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKL9609206004B1. Its current registration status is Valid, with the licence valid until 7 March 2028. The product is registered to IFARS PHARMACEUTICAL LABORATORIES - INDONESIA. BPOM first approved this registration in August 2024. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: Registrasi Obat
Packaging: DUS, 10 STRIP @ 10 KAPLET
Department: Direktorat Registrasi Obat
Data Last Updated: 13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

IFARS PHARMACEUTICAL LABORATORIES - INDONESIA
KAB. KARANGANYAR
NPWP: 011323623528000
owner
View profile →

Manufacturing Sites

IFARS PHARMACEUTICAL LABORATORIES - INDONESIA
KAB. KARANGANYAR
primary
View profile →

Ingredients (1)

NAPROXEN SODIUM

Market Intelligence

Owner Portfolio: IFARS PHARMACEUTICAL LABORATORIES - INDONESIA holds 253 BPOM registrations
Manufacturer Scale: IFARS PHARMACEUTICAL LABORATORIES - INDONESIA produces 253 registered products
Registration Age: Registered for 1 year, 11 months

Is this your product?